Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Maternal Serum Adropin as a Potential Biomarker for Placenta Accreta Spectrum

NCT07421180 is registered in ClinicalTrials.gov with Adana City Training and Research Hospital as lead sponsor.

NCT NCT07421180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07421180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Maternal Serum Adropin as a Potential Biomarker for Placenta Accreta Spectrum
Lead sponsor
Adana City Training and Research Hospital
Phase
Observational
Overall status
Completed
Start date
May 15, 2024
Completion date
April 1, 2025
Enrollment
84 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

placenta accreta spectrum, placenta previa